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Abstract Recent studies indicate that adenosine may influ-
ence dopamine neurotransmission via A2A receptors which
antagonistically interact with D2 receptor-mediated signaling
in the brain.We examined the effects of selective A2A receptor
ligands such as the agonist CGS 21680 and the antagonists
KW 6002 or SCH 58261 as well as of the D2-like receptor
antagonist raclopride on reinstatement of cocaine seeking
induced by cocaine, the cocaine-conditioned cue, or the D2-
like receptor agonist quinpirole in rats. For comparison, ef-
fects of the A2A receptor ligands on reinstatement of food
seeking were also studied. CGS 21680 significantly attenuat-
ed the reinstatement of cocaine (ip) seeking, and even more
potently it reduced quinpirole (ip) or the cue-induced relapse
of cocaine seeking as well as cue-induced food seeking. A
potent reduction toward the cocaine-, quinpirole-, or cue-
induced reinstatement of cocaine seeking was seen with
raclopride. Pretreatment with KW 6002 or SCH 58261 rein-
stated cocaine seeking, and such increases were blocked by
raclopride. In the higher doses, KW 6002 or SCH 58261
evoked food-seeking. In combination with the subthreshold
dose of cocaine (2.5 mg/kg) or with the cue, low doses of KW
6002 but not SCH 58261 reinstated cocaine-seeking behavior,
while none of the A2A receptor antagonists affected the cue-
induced food-seeking behavior. The results indicate that A2A
activation and D2-like receptor blockade counteract cocaine
and food relapse. It is proposed that A2A receptor- and D2
receptor-mediated adenosine and dopamine signaling antago-
nistically interact in the striato-pallidal GABA neurons to
regulate cocaine and food-seeking behavior.
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Introduction
Cocaine addiction is characterized by an inability of addicts to
inhibit drug use relapse triggered by drugs, environmental
cues, or stressful life events (Belin et al. 2013; Everitt and
Heberlein 2013). Similar factors are active in a rat model of
relapse where animals extinguished from cocaine self-
administration reinstate seeking behavior following co-
caine priming dose, the drug-paired conditioned stimu-
lus, or stressors (Fuchs et al. 1998; Markou et al. 1993).
The neuronal basis of cocaine relapse includes activa-
tion of the mesocorticolimbic circuitry with changes in
glutamate and dopamine (DA) neurotransmissions
(Kalivas 2009; Sinha 2013).
Recent data indicate that adenosine may influence DA and
glutamatergic neurotransmission, especially in the striatal re-
gion (Fuxe et al. 2007a, 2008). As shown for adenosine and
DA signaling in striato-pallidal γ-aminobutyric acid (GABA)
neurons, D2 receptor-mediated DA transmission can be re-
duced by A2A receptor agonists, while A2A receptor antago-
nists increase it (Filip et al. 2012; Fuxe et al. 2007b, 2010).
Stimulation of D2 receptors in the ventral and dorsal striatum
is involved in mediating the locomotor, sensitizing, and re-
warding effects of cocaine or other drugs of abuse, and these
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actions are antagonized by activation of A2A receptors
(Bachtell and Self 2009; Filip et al. 2006, 2012; Jastrzębska
et al. 2014; Knapp et al. 2001).
The role of A2A receptors in cocaine relapse in the frame of
the antagonistic interactions in A2A receptor and D2 receptor-
mediated adenosine and DA signaling, respectively, has not
been fully investigated so far. The aim of this study was to
examine the role of A2A receptors, using two selective antag-
onists (KW 6002 or SCH 58261) in cocaine-seeking behavior
evoked by cocaine, the D2-like receptor agonist quinpirole, or
the cue. The dependency on D2 receptors was tested with the
D2-like antagonist raclopride. The two used A2A receptor
antagonists may possibly differentially influence mechanisms
at pre- and postsynaptic sites in the rat striatum, as KW6002 is
the postsynaptic A2A receptor antagonist while SCH 58261 is
regarded as the mixed post- and presynaptic receptor antago-
nist (Filip et al. 2012). For comparison, effects of the A2A
receptor antagonists on reinstatement of food-seeking behav-
ior were studied. To extend the existing knowledge on how
A2A receptor stimulation may oppose D2 receptor signaling in
the rat ventral striatum to reduce cocaine relapse (Bachtell and
Self 2009; O’Neill et al. 2012), we also examined the effects




Male Wistar rats (Charles River, Sulzfeld, Germany) weighing
280–300 g were used. The animals were housed individually in
clear transparent home cages with free access to food (VRF1(p)
pellets, UK) and water, at a room temperature of 20±1 °C and
at a 40–50 % humidity on a 12-h light–dark cycle (the light on
at 6:00). During few days of initial lever press training per-
formed in standard operant chamber (Med-Associates, USA),
animals had limited access to water (rats used for cocaine self-
administration) or food (rats used for food self-administration).
Later on, rats used in cocaine self-administration procedures
including extinction and reinstatement testing had free access to
water and pellets, while those used in the food self-
administration procedures including extinction and reinstate-
ment testing had free access to water and limited pellet intake
(20 g) after each session. On Saturdays, following experimental
sessions, each rat used for food self-administration received
40 g of pellets. All the experiments were conducted during the
light phase of the light–dark cycle (between 0700 and 1600
hours) and were carried out in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals and with the approval of the Animal Care and Use
Committee of the Institute of Pharmacology, Polish Academy
of Sciences in Krakow.
Drugs
Cocaine hydrochloride (Sigma-Aldrich; USA), (E)-1,3-
diethyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dhydro-H-pu-
rine-2,6-dione hydrochloride, istradefylline (KW 6002;
Tocris, UK), 7-(2-phenylethyl)-5-amino-2-(2-furyl)-
pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine hydrochlo-
ride (SCH 58261; Tocris, UK), 4-[2-[[6-amino-9-(N-ethyl-β-
D - r i b o f u r a n u r o n a m i d o s y l ) - 9 H - p u r i n - 2 -
yl]amino]ethyl]benzene propanoic acid hydrochloride (CGS
21680; Tocris, UK) and trans-(e)-(4aR)-4,4a,5,6,7,8,8a,9-
octahydro-5-propyl-1H-pyrazolo[3,4-g]quinol ine
monohydrochloride ((−)quinpirole; Sigma-Aldrich, USA),
and (3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-
hydroxy-6-methoxy-benzamide) raclopride; Tocris, UK) were
used. Cocaine, (−)quinpirole, CGS 21680, and raclopride
were dissolved in 0.9 % NaCl; KW 6002 was dissolved in a
mixture (1:1:8) of dimethyl sulfoxide (DMSO, Sigma-
Aldrich, USA), Tween®80 (Sigma-Aldrich, USA), and
0.9 % NaCl, while SCH 58261 was dissolved in 1 %
DMSO. (−)Quinpirole, CGS 21680, KW 6002, SCH 58261,
and raclopride were injected ip 5, 10, 20, 30, and 40 min,
respectively, before behavioral scoring in a volume of 0.1 ml/
kg. Cocaine was administered iv in a volume of 0.1 ml per
infusion or ip in a volume 0.1 ml/kg. Doses and pretreatment
times of A2A and D2 receptor ligands were established based
on previous behavioral studies (Bachtell and Self 2009; Filip
et al. 2006; Jastrzębska et al. 2014; Knapp et al. 2001; O’Neill
et al. 2012; Wydra et al. 2014).
Cocaine self-administration and extinction/reinstatement
procedures
After 18-h water deprivation, animals were trained for 3 days
to press a lever for 1 h daily in standard operant chambers
(Med-Associates, USA) under a fixed ratio (FR) schedule 1 of
water reinforcement. Two days after lever-pressing training
and free access to food and water, the animals were implanted
with a silastic®catheter in the external jugular vein, as de-
scribed previously (Wydra et al. 2013). Catheters were flushed
daily with 0.1 ml of a heparinized saline solution (70 U/ml,
Biochemie, Austria) and 0.1 ml of a cephazolin solution
(10 mg/ml Biochemie GmbH, Austria). Catheter patency
was tested periodically or whenever an animal displayed
behavior beyond baseline parameters using methohexital
(10 mg/kg, iv), which induced the loss of consciousness
within 5 s. No problems with catheter patency were reported
in the tested rats. Rats were allowed 10 days to recover from
surgery before the start of the experiments. Later on, all
animals began lever pressing for cocaine reinforcement during
2-h daily sessions performed 6 days/week. Each completion
of a FR 1 schedule on the “active” lever resulted in a 5-s
injection of cocaine (0.5 mg/kg per infusion) together with a
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presentation of conditioned stimulus (light + tone). Following
each injection, there was a 20-s time-out period during which
responding was recorded but had no programmed conse-
quences. Response on the “inactive” lever never resulted in
cocaine delivery. Acquisition of the conditioned operant re-
sponse lasted a minimum 9 days until subjects met the fol-
lowing criteria: minimum requirement of 24 reinforcements
and active lever presses with average of six consecutive days
varied by <10 % (Wydra et al. 2013). Next, the extinction
procedure was carried out during which rats had 2-h daily
training sessions with no cocaine delivery or presentation of
the conditioned stimulus. Once they reached the extinction
criteria (a minimum of ten extinction days with the responding
to the active lever below 10% of the level observed during the
three consecutive days of maintenance. Separate groups of
animals were tested for response reinstatement induced by a
non-contingent presentation of cocaine (2.5 and 10mg/kg, ip),
a conditioned cue (tone + light previously paired with cocaine
self-administration), quinpirole (0.125–0.5 mg/kg, ip), or A2A
receptor antagonists alone.
The effects of raclopride (0.1–0.4 mg/kg, ip) were tested on
cocaine (10 mg/kg, ip), conditioned cue, quinpirole
(0.5 mg/kg, ip), KW6002, or SCH 58261 induced cocaine
seeking. Furthermore, the effect of a subthreshold dose of the
receptor A2A antagonists with cocaine (2.5 mg/kg, ip) or cue
was investigated on cocaine seeking. During the reinstatement
tests (2-h sessions), active lever presses on the FR 1 schedule
resulted in intravenous injection of saline only. Drug combi-
nation was given in a randomized order in maximum of three
reinstatement tests. Each rat underwent only one type of the
reinstatement procedure (cocaine, cue, or A2A and D2 receptor
ligands) in maximally three reinstatement tests. The order of
injections was counterbalanced according to a Latin square
design, and the test sessions were separated by at least two to
three baseline days of the extinction sessions.
Food self-administration and extinction/reinstatement
procedures
Food self-administration was conducted in a similar manner to
cocaine self-administration, as described previously (Wydra
et al. 2013). Food (pellet)-restricted rats (20 g/rat/day) were
trained to press the lever in standard operant chambers (Med-
Associates, St. Albans, GA, USA) under a FR 1 schedule of
reinforcement (each completion of a FR 1 schedule on the
“active” lever resulted in a delivery of the portion of sweet-
ened milk (0.1 ml)) in daily 2-h sessions. Response on the
“inactive” lever never resulted in sweetened milk delivery.
Training and maintenance sessions occurred over a total of
14–16 days during which subjects met acquisition criteria that
required the number of reinforcements and active lever
presses over six consecutive maintenance sessions to vary
by only 10 %. Once stable rates of responding were
established, the extinction procedure started on the following
day. During extinction sessions, subjects had 2-h daily train-
ing sessions with no delivery of sweetened milk. Once they
reached the extinction criteria (a minimum of ten extinction
days with the responding on the active lever below 10% of the
level observed during maintenance during at least three con-
secutive days), rats were divided into separate groups to run
reinstatement tests evoked by either a presentation of sweet-
ened milk or a cue (tone) previously paired with sweetened
milk delivery. During the cue reinstatement tests (2-h ses-
sions), active lever presses on the FR 1 schedule did not result
in sweetened milk delivery. Separate groups of animals were
tested for response reinstatement induced by a contingent
presentation of sweetened milk, or a conditioned cue (tone
previously paired with self-administered sweetened milk), or
by A2A receptor antagonists alone. Each rat underwent only
one type of the reinstatement procedure (sweetened milk, cue,
or A2A receptor antagonists) in maximally three reinstatement
tests. The order of injections was counterbalanced according
to a Latin square design, and the test sessions were separated
by at least two to three baseline days of the extinction sessions.
Statistical analyses
The number of responses on the active and inactive levers and
the number of sweetened milk reinforcements are shown as
mean (±SEM). The effects of cocaine, cue, A2A, and D2
receptor ligands during reinstatement tests on the lever presses
were analyzed using the two-way ANOVA for factors treat-
ment, lever, and treatment × lever interaction or with three-
way ANOVA for factors pretreatment, treatment, lever, and
pretreatment × treatment × lever interaction. Post-hoc analyses
for significant effects were performed with the Newman–
Keuls’ test. A one-way ANOVA was used to analyze the
number of sweetened milk reinstatement followed by the
post-hoc Dunnett’s test to show differences between group
means. A priori comparison with Student’s t test was included
to analyze the effect of food reinstatement. The criterion for
statistically significant differences was p<0.05.
Results
Reinstatement of cocaine-seeking behavior
After about nine experimental sessions, rats met the criterion
of a stable cocaine (0.5 mg/kg/infusion) self-administration.
During maintenance phase, the mean numbers of responses
emitted on active lever ranged from 38 to 46, while the
number of inactive lever presses did not exceed 7. The
daily mean cocaine intake amounts to 12.5–15 mg/kg/day.
Neither lever responding nor cocaine intake varied between
groups of rats.
Psychopharmacology (2015) 232:1767–1778 1769
Effects of cocaine, quinpirole, or cue
After 10 days of extinction trials, the rats were tested
for the response reinstatement induced by cocaine (2.5
or 10 mg/kg, ip; Fig. 1a), or quinpirole (0.125, 0.25, or
0.5 mg/kg, ip; Fig. 1b), or presentation of the cue
paired earlier with cocaine infusions (Fig. 2c). The
two-way ANOVA (treatment × lever interaction) indicated a
significant effect of cocaine (F2.36=10.61, p<0.01),
quinpirole (F3.48=2.95, p<0.05), and cue (F1.23=24.29,
p<0.001) on cocaine-seeking behavior.
The post-hoc Newman-Keuls test revealed that cocaine
(10 mg/kg), quinpirole (0.5 mg/kg), and the cue significantly
enhanced responding on the active lever (p<0.001) without
any changes in the number of inactive lever presses.
Effects of the A2A receptor agonist CGS 21680 on cocaine-,
quinpirole-, or cue-induced reinstatement
The two-way ANOVA for treatment × lever interaction
indicated a significant effect of CGS21680 (0.1–
0.4 mg/kg) on cocaine (10 mg/kg)-induced reinstatement
(F3.48=3.86, p<0.05). The post-hoc Newman-Keuls test
revealed that CGS 21680 in doses of 0.2 and 0.4 mg/kg
reduced the number of active lever presses (p<0.01)
without any changes in the number of inactive lever
presses (Fig. 2a).
The two-way ANOVA for treatment × lever interac-
tion indicated a significant effect of CGS21680 (0.05–
0.4 mg/kg) on quinpirole (0.5 mg/kg)-induced reinstate-
ment (F3.48=2.95, p<0.05). The post-hoc Newman-
Keuls test revealed that CGS 21680 dose-dependently
and significantly (p<0.01 for the lowest dose, and p<0.001
for the higher doses) reduced the number of active lever
presses without any changes in the number of inactive lever
presses (Fig. 2b).
The two-way ANOVA for treatment × lever interaction
indicated a significant effect of CGS 21680 (0.05–0.1 mg/kg)
on cue-induced reinstatement (F2.34=3.83, p<0.05). The post-
hoc Newman-Keuls test revealed that CGS 21680 in doses of
0.05 and 0.1 mg/kg reduced the number of active lever presses
(p<0.01 and p<0.001, respectively) without any changes in
the number of inactive lever presses (Fig. 2c).
Effects of the D2-like receptor antagonist raclopride
on cocaine-, quinpirole-, or cue-induced reinstatement
The two-way ANOVA for treatment × lever interaction indi-
cated a significant effect of raclopride (0.2–0.4 mg/kg) on
cocaine-induced reinstatement (F2.30=5.00, p<0.01). The
post-hoc Newman-Keuls test revealed that raclopride in doses
of 0.2 and 0.4 mg/kg significantly (p<0.01 at the low dose,
and p<0.001 at the high dose) reduced the number of active
lever presses without any changes in the number of inactive
lever presses (Fig. 3a).
The two-way ANOVA for treatment × lever interac-
tion indicated a significant effect of raclopride (0.2–
0.4 mg/kg) on quinpirole-induced reinforcement
(F2.28=3.87, p=0.03). The post-hoc Newman-Keuls test
revealed that raclopride in doses of 0.2 and 0.4 mg/kg
significantly (p<0.05 at the low dose, and p<0.001 at
the high dose) reduced the number of active lever presses
without any changes in the number of inactive lever presses
(Fig. 3b).
The two-way ANOVA for treatment × lever interac-
tion indicated a significant effect of raclopride (0.1–
0.2 mg/kg) on the cue-induced reinstatement (F2.32=
15.03, p<0.001). The post-hoc Newman-Keuls test re-
vealed that raclopride in both doses, 0.1 and 0.2 mg/kg,
highly significantly (p<0.001) reduced the number of
active lever presses without any changes in the number
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A BFig. 1 Effects of cocaine
(COC; a) and quinpirole (QUI; b)
on the reinstatement of
cocaine-seeking behaviors in rats
extinguished from cocaine
(0.5 mg/kg) self-administration.
The number of active and inactive
lever presses is shown as mean
(±SEM) for six to eight
rats/group. ***p<0.001 vs.
vehicle (VEH) + vehicle
(Newman-Keuls test)
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Effects of the A2A receptor antagonists KW 6002
and SCH 58261
The two-way ANOVA for treatment × lever interaction
did not indicate a significant effect of KW 6002
(0.0625–0.5 mg/kg) on cocaine-seeking behavior
(F4.52=1.50, p=0.21). However, the one-way ANOVA
analysis showed a significant effect of KW 6002 on
active (F4.25=4.96, p<0.01) and inactive (F4.25=6.68,
p<0.001) levers. The post-hoc Dunnett’s test revealed
that KW 6002 in doses of 0.25 and 0.5 mg/kg signifi-
cantly (p<0.01 and p<0.05, respectively) increased the
number of active lever presses. Additionally, KW 6002 in a
dose of 0.5 mg/kg increased (p<0.001) the number of inactive
lever presses (Fig. 4a).
The two-way ANOVA for treatment × lever interaction
indicated a significant effect of SCH 58261 (0.25–2 mg/kg)
on cocaine-seeking behavior (F4.50=1.51, p=0.05). The post-
hoc Newman-Keuls test revealed that SCH 58261 in a dose of
2 mg/kg increased the number of active lever presses (p<0.01)
without any changes in the number of inactive lever presses
(Fig. 4b).
Effects of the A2A receptor antagonists KW 6002 and SCH
58261 on cocaine- or cue-induced reinstatement
The three-way ANOVA for pretreatment × treatment ×
lever interaction indicated a significant effect of KW
6002 (0.0625 mg/kg) on a subthreshold dose of cocaine
(2.5 mg/kg) for reinstatement (F1.46=4.343, p<0.05).
The post-hoc Newman-Keuls test revealed that KW
6002 in a dose of 0.0625 mg/kg in combination with cocaine
(2.5 m/kg) increased the number of active lever presses
(p<0.001) without any changes on the number of inactive
lever presses (Fig. 5a).
The three-way ANOVA for pretreatment × treatment ×
lever interaction indicated a nonsignificant effect of SCH
58261 (0.5 mg/kg) on a subthreshold dose of cocaine
(2.5 mg/kg) for reinstatement (F1.54=0.179; p=0.67)
(Fig. 5b).
The three-way ANOVA for pretreatment × treatment ×
lever interaction indicated a significant effect of KW 6002
(0.125 mg/kg) on cue-induced reinstatement (F1.48=5.43,
p<0.05). The post-hoc Newman-Keuls test revealed that










































































Fig. 2 Effects of the A2A receptor
agonist CGS 21680 (CGS) on
cocaine- (COC, 10 mg/kg; a),
quinpirole- (QUI, 0.5 mg/kg; b),
or cue- (light and tone previously
associated with cocaine self-
administration; c) induced
reinstatement of cocaine-seeking
behaviors in rats extinguished
from cocaine (0.5 mg/kg) self-
administration. The number of
active and inactive lever presses is
shown as mean (±SEM) for six to
eight rats/group. ***p<0.001
vs. vehicle (VEH) + VEH;
^^^p<0.01 vs. VEH + COC;
&&p<0.01, &&&p<0.001 vs.
VEH + QUI 0.5; ##p<0.01,
###p<0.001 vs. VEH + CUE
(Newman-Keuls test)
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cue increased the number of active lever presses (p<0.001)
without any changes in the number of inactive lever presses
(Fig. 5c).
The three-way ANOVA for pretreatment × treatment × lever
interaction indicated a nonsignificant effect of SCH 58261
(0.5 mg/kg) on cue-induced reinstatement (F1.40=2.24, p=
0.142), while the two-way ANOVA for treatment × lever inter-
action indicated a significant effect (F1.20=36.20, p<0.001;
Fig. 5d). However, the post-hoc Newman-Keuls test did not
reveal any effect of SCH 58261 in combination with the cue.
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Fig. 3 Effects of the D2-like
receptor antagonist raclopride
(RACL) on cocaine-
(COC, 10 mg/kg; a),
quinpirole- (QUIN,
0.5 mg/kg; b), or cue- (light
and tone previously associated
with cocaine self-administration;
c) induced reinstatement of
cocaine-seeking behaviors in
rats extinguished from cocaine
(0.5 mg/kg) self-administration.
The number of active and inactive
lever presses is shown as mean
(±SEM) for five to seven
rats/group. ***p<0.001 vs.
vehicle (VEH) + VEH and VEH;
^^p<0.01, ^^^p<0.001 vs.
VEH + COC; $p<0.05,
$$$p<0.001 vs. VEH + QUI 0.5;
###p<0.001 vs. VEH + CUE
(Newman-Keuls test)
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Fig. 4 Effects of the A2A receptor antagonists KW 6002 (KW, 0.0625–
0.5 mg/kg; a) and SCH 58261 (SCH, 0.25–2 mg/kg; b) on the
reinstatement of cocaine-seeking behaviors in rats extinguished from
cocaine (0.5 mg/kg) self-administration. The number of active and
inactive lever presses is shown as mean (± SEM) for six to eight
rats/group. **p<0.01 vs. vehicle (VEH) (Newman-Keuls test); ^p<0.05,
^^p<0.01 vs. VEH (active lever), ###p<0.001 vs. VEH (inactive lever)
(Dunnett’s test)
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Effects of the D2-like receptor antagonist raclopride on KW
6002- or SCH 58261-induced reinstatement
The two-way ANOVA for treatment × lever interaction
indicated a significant effect of raclopride (0.2–
0.4 mg/kg) on KW 6002-induced reinstatement for ac-
tive lever presses (F2.24=4.75, p<0.01). The post-hoc
Newman-Keuls test revealed that raclopride in doses of 0.2
and 0.4 mg/kg significantly (p<0.01 at the low dose, and
p<0.001 at the high dose) reduced the number of active lever
presses without any changes in the number of inactive lever
presses (Fig. 6a).
The two-way ANOVA for treatment × lever interac-
tion did not indicate a significant effect for raclopride
(0.1–0.2 mg/kg) on SCH 58261-induced reinstatement
(F2.30=2.19, p=0.13), while the one-way ANOVA
showed reduced number of active lever presses at
0.2 mg/kg of raclopride (F2.15=4.26, p<0.05) without any
changes in the number of inactive lever presses (F2.15=2.23,
p=0.14; Fig. 6b).
Reinstatement of food-seeking behavior
After about 14 experimental sessions rats met the criterion of a
stable food (sweetened milk) self-administration. During
maintenance phase, the mean numbers of responses emitted
on active lever ranged from 1,300 to 1,400, while the number
of inactive lever presses did not exceed 30. The daily mean
sweetened milk intake ranged from 240 to 250 portions.
Neither lever responding nor sweetened milk intake varied
between groups of rats.
Effects of food or cue
After 10 days of extinction trials, the rats were tested for the
response reinstatement induced by sweetened milk (Fig. 7a, b)
or presentation of the cue paired earlier with sweetened milk
delivery (Fig. 7c). Both reinstatement of sweetened milk
delivery and the cue significantly enhanced responding on
the active lever (p<0.001) without any changes in the number
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Fig. 5 Effects of the A2A receptor
antagonists KW 6002 (KW) and
SCH 58261 (SCH) on cocaine-
(COC, 2.5 mg/kg; a, b) or
cue- (light and tone previously
associated with cocaine
self-administration; c, d) induced
reinstatement of cocaine-seeking
behaviors in rats extinguished
from cocaine (0.5 mg/kg) self-
administration. The number of
active and inactive lever presses is
shown as mean (±SEM) for six to
eight rats/group. ***p<0.001 vs.
vehicle (VEH) + VEH,
^^^p<0.001, ^^^^p<0.0001 vs.
VEH + (−); aaaap<0.0001; vs.
VEH + CUE; ####p<0.0001 vs.
VEH + KW 0.125 (Newman-
Keuls test)
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Effects of the A2A receptor agonist CGS 21680
on food- or cue-induced reinstatement
The two-way ANOVA for treatment × lever interaction indi-
cated a significant effect of CGS21680 (0.025–0.1 mg/kg) on
sweetened milk-induced reinstatement for lever presses
(F3.56=5.36, p<0.01). The post-hoc Newman-Keuls test re-
vealed that CGS 21680 in doses of 0.05 and 0.1 mg/kg sig-
nificantly (p<0.05 at the low dose, p<0.001 at a high dose)
reduced the number of active lever presses, without any
changes in the number of inactive lever presses (Fig. 7a).
The one-way ANOVA did not indicate a significant effect
of CGS 21680 (0.025–0.1 mg/kg) on sweetened milk rein-
forcement (F3.28=0.624, p=0.61; Fig. 7b). However, a
priori comparison with Student’s t test indicated a significant
effect of sweetened milk reinstatement (dt=−10.87,
p<0.00001; Fig. 7b).
The two-way ANOVA for treatment × lever interaction
indicated a significant effect of CGS21680 (0.025–0.05 mg/kg)
on the cue-induced reinstatement (F2.42=10.57, p<0.001). The
post-hoc Newman-Keuls test revealed that CGS 21680 in both
doses, 0.025 and 0.05 mg/kg, significantly (p<0.001) reduced
the number of active lever presses, without any changes in the
number of inactive lever presses (Fig. 7c).
Effects of the A2A receptor antagonists KW 6002 and SCH
58261
The two-way ANOVA for treatment × lever interaction indi-
cated a significant effect of KW 6002 (0.025–0.5 mg/kg) on
food (sweetened milk)-seeking behavior (F2.42=6.86,
p<0.01). The post-hoc Newman-Keuls test revealed that
KW 6002 in a dose of 0.5 mg/kg increased the number of
active lever presses (p<0.001) without significant changes in
the number of inactive lever presses (Fig. 8a).
The two-way ANOVA for treatment × lever interaction
indicated a significant effect of SCH 58261 (1–4 mg/kg) on
food (sweetened milk)-seeking behavior (F3.56=3.84,
p<0.01). The post-hoc Newman-Keuls test revealed that
SCH 58261 in a dose of 4 mg/kg significantly increased the
number of active lever presses (p<0.001) without changes in
the number of inactive lever presses (Fig. 8b).
Effects of the A2A receptor antagonists KW 6002 and SCH
58261 on cue-induced reinstatement
The three-way ANOVA for pretreatment × treatment × lever
interaction did not indicate a significant effect for KW 6002,
0.25 mg/kg (F1.56=0.29, p=0.59) or SCH 58261, 1 mg/kg
(F1.56=2.19, p=0.15) on the cue induced reinstatement
(Fig. 9a, b). However, the two-way ANOVA for treatment ×
lever interaction showed a significant effect of the cue (F1.28=
5.23, p<0.05; Fig. 9a, and F1.28=18.66, p<0.001; Fig. 9b).
Discussion
The current results on the actions of the A2A receptor agonist
CGS 21680 and the A2A receptor antagonists KW 6002 and
SCH 58261 on cocaine seeking give strong support to the
view that A2A receptor mechanisms in the rat brain block
reinstatement of cocaine seeking evoked by cocaine priming
or the drug-associated cue. The inhibitory actions of CGS
21680 towards cocaine- or quinpirole-induced reinstatement
of seeking behaviors in rats were in line with previous studies
using ip or intra-accumbal A2A receptor agonist infusions
(Bachtell and Self 2009; O’Neill et al. 2012). The mechanism
can involve a counteraction of the D2 receptor- mediated
cocaine seeking. In agreement with this hypothesis, CGS
21680 was four times more powerful in counteracting the
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Fig. 6 Effects of the D2-like
receptor antagonist raclopride
(RACL) on KW 6002- (KW,
0.125 mg/kg; a) and SCH 58261-
(SCH, 2 mg/kg; b) induced
reinstatement of cocaine-seeking
behaviors in rats extinguished from
cocaine (0.5 mg/kg) self-
administration. The number of
active and inactive lever presses is
shown as mean (±SEM) for six
rats/group. ***p<0.001 vs. vehicle
(VEH) + VEH (Newman-Keuls
test); ^^p<0.01, ^^^p<0.001 vs.
VEH + KW 0.125 (Newman-
Keuls test), #p<0.05 vs. VEH +
SCH 2 (Dunnett’s test)
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D2-like receptor agonist quinpirole-induced relapse versus
cocaine-induced relapse. Of note, CGS 21680—in a similar
dose that brought down quinpirole-evoked cocaine seeking—
was also a very effective blocker of the cue-induced relapse.
Similarly to cocaine seeking, food (sweetened milk) seek-
ing appears to be under an inhibitory A2A receptor control as
CGS 21680 with a similar potency as observed in the above
studies on cocaine seeking reduced reinstatement of active
lever presses associated with food reward.
It should be underlined that CGS 21680 (0.3–1 mg/kg, but
not 0.1 mg/kg) elevated reward thresholds in rats (Baldo et al.
1999), while in the current paper, the lower doses of CGS
21690 (0.05–0.1 mg/kg) effectively reduced reinstatement of
seeking behavior for cocaine and food. Therefore, the inhib-
itory effects of the A2A receptor agonist are not likely ex-
plained by an anhedonic state produced by this drug but may
involve restoration of inhibitory control inter alia from the
prefrontal cortex (see Chen et al. 2013). Other studies dem-
onstrated reduced effort-related food choice behavior (Font
et al. 2008) and binge-related eating disorders (Micioni di
Bonaventura et al. 2012) with activation of A2A receptors


























































































Fig. 7 Effects of the A2A receptor
agonist CGS 21680 (CGS) on
food (sweetened milk)- (a, b) or
cue- (c) induced reinstatement of
food seeking behavior in rats
extinguished from food self-
administration The number of
active and inactive lever presses
and the number of food
reinforcements is shown as mean
(±SEM) for seven to eight
rats/group. ***p<0.001 vs.
vehicle (VEH); ^p<0.05;
^^^p<0.001 vs. VEH + FOOD;
VVVp<0.001 vs. VEH;

























A BFig. 8 Effects of the A2A receptor
antagonists KW 6002
(KW, 0.25–0.5 mg/kg; a) and
SCH 58261 (SCH, 1–4 mg/kg; b)
on the reinstatement of food-
seeking behaviors in rats
extinguished from food self-
administration. The number of
active and inactive lever presses is
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this molecular target as the inhibitory mediator of food intake.
On the other hand, local injection of CGS 21680 into the
nucleus accumbens had no effect on sucrose seeking in rats
trained to self-administer sucrose pellets (O’Neill et al. 2012).
These findings may implicate presence of distinct types of
ventral striato-pallidal GABA neurons (see Carelli et al. 2000)
which express or do not express A2A receptors, and thus
differently control food intake.
It should be noticed that CGS 21680 reduced the number of
active (but not inactive) lever pressing, suggesting that the
behavioral inhibition in the above studies was likely not due to
nonspecific sedation or locomotor impairment. In fact,
CGS 21680 at doses of 0.05–0.2 mg/kg does not inhibit
locomotor activity, while at a dose of 4 mg/kg its inhibitory
actions were short-lasting (up to 15 min after drug injection)
(Wydra et al. 2014).
The impact of A2A receptor antagonists on cocaine-seeking
behavior was studied with two types of antagonists, the xan-
thine derivative KW 6002 and the non-xanthine derivative
SCH 58261 (Filip et al. 2012). They both display a similar
potency at A2A receptors; however, KW 6002—when com-
pared with SCH 58261—appears to have a somewhat higher
affinity for A2A protomers in A2A-D2 heteromers versus A2A
protomers in A1-A2A heteromers tested in the same cell line
(Orru et al. 2011). It is unknown, if this small difference also
exists in the brain. KW 6002 and SCH 58261 at a dose
of 0.25 and 2 mg/kg, respectively, significantly evoked
cocaine-seeking behavior by increasing active lever
pressing with no activity on the inactive lever. The latter
finding demonstrates that A2A receptor antagonist-induced
seeking was not caused by increases in motor activity. Such
a behavioral selectivity was lost with a higher dose of
KW 6002 (0.5 mg/kg) and the drug-induced general
motor enhancement is a factor responsible for the KW
6002 enhancement of the number of active lever presses at this
high dose.
It is of substantial interest that lower doses of KW 6002
(0.0625 mg/kg) could also induce cocaine seeking if com-
bined with a subthreshold dose of cocaine (0.25 mg/kg). The
low dose 0.125 mg/kg of KW6002 also markedly increased
the cue-induced cocaine seeking which seems to exclude a
pharmacokinetic mechanism being involved in the cocaine-
KW 6002 interaction in this experiment. It was unexpected
that low doses of another selective and potent A2A receptor
antagonist SCH 58261 (0.5 mg/kg) induced neither cocaine
seeking after the cocaine subthreshold dose nor did it signif-
icantly enhance the cue-induced cocaine seeking. The mech-
anism for this difference between the two A2A receptor antag-
onists is unknown. However, there are indications that differ-
ent A2A receptor antagonists (KW 6002 and ZM 241385) can
bind to different residues of the orthosteric binding site of A2A
receptors which can result in differential conformational dy-
namics of these receptor sites (Pang et al. 2013). It is therefore
possible that the conformational rearrangement produced by
KW 6002 is more effective than SCH 58261 to antagonize
A2A receptor signaling. As a result, D2 signaling using low
doses of A2A receptor antagonists is only sufficiently in-
creased with KW 6002 which is associated with relapse or
elevation in cocaine seeking.
With regard to food intake, both KW 6002 and SCH 58261
used in similar doses to enhance cocaine seeking were also
able to induce food-reinforced instrumental responding. An
interesting difference towards cocaine seeking was that KW
6002 and SCH 58261 did not enhance cue-induced food
seeking for unknown reasons. One explanation may be that
the subsets of striato-pallidal GABA neurons involved in cue-
induced food seeking do not express A2A receptors in contrast
to the subsets involved in cue-induced cocaine seeking. Since
the inactive lever presses during reinstatement tests were not
significantly increased after A2A receptor antagonists, as dem-
onstrated in the current study, the possible enhancing effects









































A BFig. 9 Effects of the A2A receptor
antagonist KW 6002 (KW; a) and
SCH 58261 (SCH; b) on
cue-induced reinstatement
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motor function in animals with a history of cocaine self-
administration.
A likely mechanism by which A2A receptors control drug-
seeking behavior depends on a basal activity of A2A receptors
produced by extracellular adenosine which operates via vol-
ume transmission (Fuxe et al. 2010). Various studies have
revealed that glutamatergic transmission in different pathways
from the prefrontal cortex to the nucleus accumbens can
mediate or inhibit reinstatement of drug-seeking for cocaine
or cue (Chen et al. 2013; Cornish and Kalivas 2000; Di Ciano
et al. 2001; Knackstedt and Kalivas 2009; Kravitz et al. 2012;
Lobo et al. 2010). It has been demonstrated with optogenetic
tools that activation of the D1 receptor positive medium spiny
neurons of the nucleus accumbens will enhance cocaine re-
ward while increased firing of the D2 receptor positive medi-
um spiny neurons within this region will suppress cocaine
reward by mediating punishment (Lobo et al. 2010; Kravitz
et al. 2012). Since most of A2A receptors are located in the
latter pathway representing the ventral striato-pallidal GABA
neurons, our hypothesis is that the A2A receptor agonist
inhibits cocaine- and food-seeking behavior by targeting
the A2A receptors in the accumbens GABA neurons projecting
to the ventral pallidum which is postulated to increase their
firing rate.
A2A-D2 heteroreceptor complexes were discovered in cel-
lular models and in the brain using FRET-BRET methodolo-
gies and in situ Proximity Ligation Assays (Fuxe et al. 2008;
Trifilieff et al. 2011; Borroto-Escuela et al. 2013a, b). In
membrane preparations from cell lines and brain regions,
A2A receptor agonists reduced the affinity and Gi/o coupling
of D2 receptors likely taking place in A2A-D2 heteroreceptor
complexes (Yang et al. 1995; Dasgupta et al. 1996; Fuxe et al.
2008, 2010; Borroto-Escuela et al. 2010a). It is therefore
speculated that the molecular mechanism underlying the
actions of the A2A receptor ligands on cocaine and food
seeking can involve antagonistic A2A-D2 receptor-receptor
interactions at the plasma membrane level in heteroreceptor
complexes and/or at the cytoplasmatic level in their signaling
cascades in the striato-pallidal GABA neurons (Filip et al.
2012; Fuxe et al. 2010, 2014). Thus, it is possible that cocaine
seeking may be counteracted to a substantial degree through
the A2A receptor agonist activation of the A2A protomer
reducing the D2 protomer signaling of the A2A-D2
heteroreceptor complex. In support of this proposal, evidence
is presented that the D2-like antagonist raclopride
counteracted the cocaine-, quinpirole-, or cue-induced rein-
statement of cocaine-seeking behavior.
After treatment with A2A receptor antagonists, it is instead
speculated that the D2 receptor protomer signaling is set free
from the restraining impact of the A2A protomer in the A2A-D2
heteroreceptor complex which can help elicit the cocaine
reinstatement. Based on these findings, it is postulated
that in the striatum (including the nucleus acumbens) an
endogenous adenosine tone keeps A2A receptors activated
and induces a brake on the D2 receptor protomer signaling
in the A2A-D2 heteroreceptor complex in the ventral striato-
pallidal GABA neurons. In view of the well-established key
role of D2 receptors in cocaine addiction (Koob 2013), remov-
al of this brake by A2A receptor antagonists may release
cocaine-seeking behavior. However, further mechanistic stud-
ies using the A2A-D2 receptor interface interacting peptides
disrupting the A2A-D2 heteroreceptor complex are necessary
to support our hypothesis (see Borroto-Escuela et al. 2010a, b;
Fuxe et al. 2014).
Taken together, our current pharmacological studies using
one A2A receptor agonist and two A2A receptor antagonists
give strong support to the view that brain A2A receptors play a
major inhibitory role in cocaine and food seeking. The A2A
receptor agonists/antagonists are proposed to target A2A re-
ceptors in the D2 receptor positive ventral striato-pallidal
GABA neurons whichmay counteract the inhibitory influence
of D2 receptors on the activity of this pathway.
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